Gold Partners
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
PFG MedComm
Website: https://www.pfgmed.com/
Accomplishing access through value communication. That’s what we do.
PFG MedComm is a woman and minority-owned strategic market access agency that specializes in leveraging value communication to achieve access goals. We’ve transformed the traditional agency model with our unique 360° approach that considers the entire development lifecycle when planning for market access. Our proprietary process involves anticipating challenges, adapting strategic plans, and accomplishing access through seamless execution and field engagement.
As a full-service strategic market access agency, our capabilities run the gamut from the earliest stages of clinical planning and strategy through launch, training and beyond. We are experts in developing end-to-end marketing strategies and tactics across all healthcare stakeholders, (ranging from various types of payers and access decisionmakers to healthcare professionals and patients), with experience in US and international markets across EMEA, LATAM and APAC.
Our team has a broad range of experience to support medical, payer and HEOR communication strategy across pharmaceutical, biotech, medical device, and digital therapeutic companies. Over the past ten years, the PFG MedComm team has supported over 60+ brands (including 33 launches both US and global), across 50+ indications within 20+ therapeutic categories.
We take those complicated ideas and make them understandable to all stakeholders to ensure a company's drugs, therapies, devices, and diagnostics reach those who need them with minimal hurdles.
Premier Research
Website: https://premier-research.com/womenshealth
Premier Research is a clinical research, product development, and consulting company dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. With more than 100 women’s health projects conducted in the last five years, Premier Research understands the complexities of developing novel therapeutics and diagnostics for conditions that exclusively or disproportionately affect women. We are supported by a network of thousands of highly experienced women’s health sites and offer end-to-end solutions for wherever you may be in your product development journey, from concept to commercialization.
Venable LLP
Website: https://www.venable.com/
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, and high-net-worth entrepreneurs and individuals. With more than 850 professionals across the country, including California, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the U.S. and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit www.Venable.com.
Event Partners
Restful Pump
Website: https://restfulpump.com/
Founded by a mom for moms, Restful Pump® has engineered the world’s first to market premier forward leaning lactation systems for at home, at work or on the go.
Postpartum women are fatigued, sleep deprived, managing breast pumping positioning, milk supply issues, pain and/or breast tissue complications, and some addressing return to employment. Using a breast pump every 4-5 hours, 24 hours a day doesn’t have to be such an uncomfortable chore.
Now women can rest, sleep, or multitask in a supportive hands-free position, using any type of breast pump. While providing comfort, convenience, productivity, possibly reducing breast tissue complications and increasing pumping durations, our devices may even negate the need for baby formula.
Restful Pump® is solving a global problem with novel Class 1 medical devices. With an MD’s prescription, and possible US reimbursement via health insurance, Restful Pump® products aim to be as medically necessary as a breast pump in the postpartum period.
With over 12 patents filed for over 10 products in 30 countries there is massive potential for safe, high-yield investments with durable medical equipment annual recurring revenue.
Pump While You Sleep®
Celanese
Website: https://bit.ly/3a0JriQ
Celanese works closely with you to develop innovative sustained-release dosage forms to help you deliver patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants and inserts, with flexibility to address a variety of formulation challenges and tailoring the release rate of your drug.
∙ Compatible with biologics, small molecules, and RNA
∙ Provides reliable local or systemic drug administration
∙ High drug loading capacity (≤ 75%)
∙ Engineered long-acting dosage profiles (zero-order or nonlinear profiles)
∙ Ease of formulation, configurable into a variety of geometries
∙ An established regulatory path with long clinical use history
From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION
Our scientists and engineers are available from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
Sheppard Mullin
Website: https://www.sheppardmullin.com/whlc
Sheppard Mullin’s Women in Healthcare Leadership Collaborative (WHLC) is an exclusive national leadership initiative committed to supporting women professionals in or advancing into leadership positions within the healthcare and life sciences industries.
WHLC was established in response to significant and persistent systemic gender disparities in institutional leadership positions in the healthcare and life sciences industries. Despite constituting a vast majority of the workforce, women continue to hold a small minority of these positions.
Drawing upon Sheppard Mullin’s nationally-ranked healthcare practice, and the law firm’s leadership in diversity and inclusion, WHLC aims to reverse this trend by providing women professionals access to critical resources and networking opportunities designed to support them as they progress in their careers. WHLC hosts regular roundtable discussions focusing on complex legal and business issues and cutting-edge innovation and developments in the healthcare industry, as well as professional skills training and development, and quality networking events connecting these professionals to other leaders in the industry. Sheppard Mullin hosts WHLC events virtually and in various locations across the country.